A new method for the determination of serum nucleotidase. V. Evaluation of the response of serum nucleotidase to bone metastases and therapy in cancer patients.
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001797:Blood Protein Electrophoresis; D001859:Bone Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology; D001842:Bone and Bones / Q000201:enzymology; D001943:Breast Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology; D002277:Carcinoma / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005969:Glutamate Dehydrogenase / Q000097:blood; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D008113:Liver Neoplasms / Q000201:enzymology; D008297:Male; D008722:Methods; D009362:Neoplasm Metastasis; D009708:Nucleotidases / Q000097:blood*; D013997:Time Factors
D004967:Estrogens; D007527:Isoenzymes; D005969:Glutamate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D009708:Nucleotidases; D000469:Alkaline Phosphatase